(Q38206081)

31 August 2017

1 reference

title

Benign prostatic hyperplasia: the best treatment (English)

1 reference

31 August 2017

prostatic hypertrophy

1 reference

Chisholm GD

1

1 reference

PMC publication ID

1836932

31 August 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

31 August 2017

1 reference

31 August 2017

299

1 reference

31 August 2017

6693

1 reference

31 August 2017

215-216

1 reference

A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy

31 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Controversies about indications for transurethral resection of the prostate.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

The Treatment of Benign Prostatic Hypertrophy with Flutamide (SCH 13521): A Placebo-Controlled Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

The pathogenesis of benign prostatic hyperplasia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Use of stents for treating obstruction of urinary outflow in patients unfit for surgery

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Clinical experience: symptomatic management of BPH with terazosin

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Aromatase inhibition in the dog. II. Effect on growth, function, and pathology of the prostate

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Balloon dilatation of the prostate for treatment of benign hyperplasia.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

II. The Question of Castration for Enlarged Prostate

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836932

Prazosin in the Treatment of Prostatic Obstruction A Placebo-controlled Study

3 December 2018

1 reference

12 December 2020

The Natural History of Untreated “Prostatism”

1 reference

12 December 2020

Effects of Prazosin in Patients with Benign Prostatic Obstruction

1 reference

12 December 2020

The testes and the prostate: a continuing relationship

1 reference

12 December 2020

Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate

1 reference

12 December 2020

The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate

1 reference

12 December 2020

The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.299.6693.215

1 reference

31 August 2017

1 reference

PMC publication ID

1836932

31 August 2017

PubMed publication ID

2475197

1 reference

PMC publication ID

1836932